Logo
Search
Home
Past Issues
Browse Compounds
How RQS Works
Logo

Past Issues

Every issue takes one compound and grades it on what the research actually shows, not the hype. Read them in any order.
The Honest Dose #22

Oct 9, 2026

•

8 min read

The Honest Dose #22

Issue #1 with retatrutide. Here's how the hype held up.

The Honest Dose #21

Oct 2, 2026

•

7 min read

The Honest Dose #21

The fat-loss peptide with a human trial that just didn't work.

The Honest Dose #20

Sep 25, 2026

•

8 min read

The Honest Dose #20

The FDA's peptide sweep: why 'for research use only' stopped working

The Honest Dose #19

Sep 18, 2026

•

9 min read

The Honest Dose #19

The peptide sold as natural TRT with human trials, just not for what it's sold for

The Honest Dose #18

Sep 11, 2026

•

8 min read

The Honest Dose #18

The peptide gray market just became a $100M financial story. Here's what that number actually means.

The Honest Dose #17

Sep 4, 2026

•

9 min read

The Honest Dose #17

The other half of the Wolverine stack, and how little we actually know.

The Honest Dose #16

Aug 28, 2026

•

12 min read

The Honest Dose #16

The first mitochondrial peptide the FDA ever approved, and the fine print underneath it

The Honest Dose #15

Aug 21, 2026

•

9 min read

The Honest Dose #15

The courtroom fight that decides what you can buy

The Honest Dose #14

Aug 14, 2026

•

8 min read

The Honest Dose #14

The peptide behind all the fertility questions in your search history

Load more

The Honest Dose | by PeptideClear

No sponsors. No agenda. Evidence-graded intel on peptides and longevity, translated for real people.

peptideclear.com

© 2026 The Honest Dose | by PeptideClear.
beehiivPowered by beehiiv